200
Views
4
CrossRef citations to date
0
Altmetric
Original Research

North American cost analysis of brand name versus generic drugs for the treatment of glaucoma

ORCID Icon, &
Pages 789-798 | Published online: 16 Dec 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Amalia Mihaela Rosu, André Coelho & Pedro Camacho. (2021) Assessment of medication therapy adherence in glaucoma: scoping review. Expert Review of Ophthalmology 16:2, pages 113-124.
Read now

Articles from other publishers (3)

Jerry K Benites-Meza, Percy Herrera-Añazco, Arón A Santillán-Rodríguez, Carlos J Zumarán-Nuñez, Luz C Barturén-Alvarado & Vicente A Benites Zapata. (2023) Association between self-medication with antibiotics and purchase of brand-name drugs: analysis of a national survey in Peru. Journal of Pharmaceutical Health Services Research 14:2, pages 112-122.
Crossref
Chandruganesh Rasendran, Ang Li & Rishi P. Singh. (2022) Incremental Health Care Expenditures Associated With Glaucoma in the United States: A Propensity Score–matched Analysis. Journal of Glaucoma 31:1, pages 1-7.
Crossref
. (2020) Brand-name drugs for glaucoma more costly than generics. PharmacoEconomics & Outcomes News 844:1, pages 9-9.
Crossref